Introduction
The issue of viral coinfection among human i m m u n o d e f i c i e n c y v i r u s ( H I V ) / a c q u i r e d immunodeficiency syndrome (AIDS) patients represents a growing public health concern worldwide. Viral coinfections among an HIV-infected individual may affect the disease progression of HIV/AIDS and may accelerate the progression of these other viral infections to more severe illness due to HIV coinfection (1) (2) (3) (4) (5) (6) (7) (8) (9) (10) . Among the list of viruses that are likely to be co-infected with HIV, hepatitis B virus (HBV), hepatitis C virus (HCV), herpes simplex virus including type 1 (HSV-1) and type 2 (HSV-2), and the Epstein-Bar virus (EBV) are the most important coinfections among HIV/ AIDS patients due to their pathogenicity and relatively high prevalence in populations affected by HIV.
HBV and HCV are of concerns because both viruses compromise liver function, which may further affect the metabolism and therapeutic effect of antiretroviral drugs (ARV) for AIDS patients (11) (12) (13) . They are also classified as group one causative agents of hepatocellular carcinoma (HCC) by International Agency for Research on Cancer (IARC). Worldwide it is estimated that 10-30% of the 40 million people infected with HIV are co-infected with HCV due to similar transmission routes between HIV and HCV (14) . In China, high prevalence of HIV and HCV coinfection has been reported among injection drug users (IDU) and plasma/blood donors (15, 16) .
HSV also plays an important role in the disease progression of HIV infection. Chronic infection of HSV-1 has been regarded by the World Health Organization (WHO) as an important factor affecting the disease progression of HIV/AIDS. HSV-1 infection is usually transmitted during childhood and adolescence and is most often transmitted via nonsexual contact (17) . On the other hand, HSV-2 is most likely to be sexually transmitted and is the leading cause of the genital ulcer disease. Studies have suggested that there is a strong association between HSV-2 and HIV serostatus and that diagnosis of HSV-2 infection can help to identify individuals at greater risk for contracting HIV (18) . In China, HSV-2 infection is relatively uncommon in the general population but is very common among female sex workers (19) (20) (21) (22) (23) (24) .
EBV is the causal agent of non-Hodgkin's lymphoma (NHL) which is an AIDS-defining malignancy. It is also the causal agent of Hodgkin's lymphoma (HL) and nasopharyngeal cancer, both of which are non-AIDS defining malignancies but have been increasingly observed among HIV/AIDS patients who have experienced long-term immunodeficiency (25, 26) . EBV is also highly prevalent around the world (27) .
In China, there has been no study specifically designed to examine the seroprevalence of viral coinfections among HIV/AIDS patients. We hypothesize that multiple pathogenic viral coinfections may negatively impact HIV-infected individuals. Therefore, as the first step to test the hypothesis, we conducted a cross-sectional seroprevalence survey of HBV, HCV, HSV-1, HSV-2, and EBV among HIV/AIDS patients from four geographical areas representing different HIV transmission routes in China. The knowledge gained from this study will shed a light on the disease progression of HIV infection in Chinese populations and will be valuable for designing effective antiretroviral treatment (ART) programs for Chinese HIV/AIDS patients.
Materials

HIV/AIDS reporting and managing system in China
In China, it is required by law that all newly identified HIV-infected cases must be reported to local centers for disease prevention and control (CDC) first and then to the national CDC through the AIDS Network Direct Reporting Information System. The local CDC is also obligated to conduct a nationwide standardized epidemiological investigation on each newly reported HIV-infected case which ascertains sociodemographic characteristics and HIV-related risky behaviors. Once the HIV-infected cases are registered in the national reporting information system, they will be regularly followed up by local CDC for behavioral interventions, provision of health care services and social support. At each follow-up visit, venous blood is drawn for testing CD4 + cell counts as an index of disease progression. The data obtained from the initial and all follow-up epidemiological investigation, interviews and medical examinations constitute the patient's personal HIV/AIDS file or database, which is located in both local and national CDC.
Study sites
The present study was conducted in four regions which were selected to represent the overall epidemiological pattern of the HIV/AIDS epidemic in China: Each of the four sites had a qualified laboratory equipped with a flow cytometer for CD4 + cell counting of HIV/AIDS patients.
Subject selection
Due to limited resources and unaffordable expenses for laboratory tests, we decided not to include all alive and traceable HIV/AIDS patients in these four study sites for this study. Instead, we selected all adult HIV/AIDS patients in these four study sites who visited local CDC for routine follow-up tests of CD4 + cell count during a specified two-week sample collection period for each site from late 2008 through early 2009. The specific two-week sample collection period designated to each site was chosen primarily based on our experience that it would allow for obtaining a reasonable size of the study sample. A total of 1,110 HIV/AIDS patients who visited local CDC during the sample collection period were included in the present study. Among them, 288 HIV/AIDS patients were from Yuncheng city, 163 were from Taizhou, 360 were from Urumqi, and 300 were from Yingjiang. These patients shown up within the two-week sample collection period represented 40% of all alive and traceable HIV patients in Yuncheng, 95% in Taizhou, 32% in Urumqi, and 18% in Yingjiang, respectively. The low representativeness in Yingjiang, Yunnan province, was due to the fact that it had a large number of alive HIV/AIDS patients and the majority of them were living in remote mountainous villages and did not visit the local CDC as often as their counterparts in other areas. Sociodemographic characteristics and HIV transmission route of the study subjects were abstracted from their individual epidemiological HIV/ AIDS files. This study was approved by the Institutional Review Board (IRB) of the corresponding institution in China.
Blood testing
To avoid drop of antibody titers due to long distance transportation, all aliquots of serum samples were cryopreserved at −20°C or −70°C and tested in the local CDC. CD4 + cell counts were measured by local CDC laboratory staff using a flow cytometry (BD FACSCount TM ; BD Biosciences, San Jose, CA, USA), who had been strictly trained and certified following the national guidelines set by the national center for AIDS and sexually transmitted disease (STD) prevention and control (NCAIDS) of China CDC. HBV surface antigen (HBsAg) and anti-HCV IgG antibody were tested using an enzyme-linked immunosorbant assay (ELISA) (Wantai Biological Pharmacy Enterprise Co., Beijing, China). HSV-1-and HSV-2-specific IgG antibodies were tested using the HerpeSelect ELISA Kit (Focus Technologies, Cypress, CA, USA). Anti-EBV nucleic antigen (EBNA) IgG antibody was tested by ELISA (Euroimmun, Lübeck, Germany). All above serological tests were performed by the same two experienced technicians from the key laboratory of the leading institution of this study, according to the manufacturers' standard protocols. Duplicate negative, positive and blank controls were always used.
Data analysis
Seroprevalence of each viral coinfection was tabulated by geographic region and sociodemographic characteristics of study subjects, followed by chisquared tests to determine statistical significance. Five separate multiple logistic regression analyses were performed to identify independent sociodemographic correlates of HBV, HCV, HSV-1, HSV-2, and EBV infection respectively among HIV/AIDS patients. Their respective odds ratios (ORs) and 95% confidence intervals were calculated. All statistical analyses were carried out using the SAS System for Windows (Cary, NC, USA), version 8.0. Table 1 presents sociodemographic characteristics of the study participants. About 45.3% of the study subjects were between 30 to 39 years and 61.5% were males. The majority of them were married and almost a half was either illiterate or educated only at primary schools. All Yuncheng patients and 93.2% of Taizhou patients were ethnic Han, whereas 92.2% of Urumqi patients and 55.7% of Yingjiang patients were ethnic minorities. Table 1 presents a detailed description of their socio-demographic characteristics which varied significantly by geographic region.
Results
Sociodemographic characteristics
HIV transmission mode and disease status
As shown in Table 1 , the means of HIV transmission varied widely by geographic region. In Yuncheng the most frequent mode of transmission was through plasma/blood donation or transfusion (85.1%). In Taizhou the majority of transmission was heterosexual (69.9%), however all modes of transmission were reported among the sample. In Urumqi the majority of the transmission reported was through injection drug use (52.8%), however the rate of heterosexual transmission was also relatively high (30.0%). In Yingjiang injection drug use was the most common transmission route (50.0%), which was followed closely by heterosexual transmission (42.0%).
About 42.7% of the patients were receiving ART, and 32.1% had 200-349 CD4 + cells/μL and 23.4% had less than 200 CD4 + cells/μL (Table 1 ).
Prevalence of viral coinfections
The overall seroprevalence was 6.3% for HBV, 59.0% for HCV, 96.6% for EBV, 91.5% for HSV-1, and 34.1% for HSV-2 ( Table 2 ). The seroprevalence of all five viruses except for HBV varied significantly by geographic region, most sociodemographic the five viruses. The most common combination of coinfections was with HCV, EBV, and HSV-1, which accounted for 36.8% of study subjects (Table 3) .
Correlates of viral coinfections
The results of multiple logistic regression analyses were shown in Table 4 . Sociodemographic characteristics and HIV transmission mode were not significantly correlated with coinfections of HBV, EBV, and HSV-1 among the study subjects (data not shown with geographic region, age, gender, ethnicity, marital status, and HIV transmission mode. HIV patients who were living in Taizhou, Eastern China, were female or divorced/widowed, were less likely to have an HCV coinfection. Those who aged more than 30 years, were ethnic Jingpo or infected with HIV through drug injection or plasma/blood donation or transfusion were more likely to be co-infected with HCV. On the contrary, coinfection with HSV-2 was significantly higher among those who were living in areas other than Yuncheng city in central China or female. However, those who were ethnic Dai or Jingpo were less likely to have an HSV-2 coinfection than ethnic Han. Those who became infected with HIV through plasma/blood donation or transfusion were less likely to have an HSV-2 coinfection than those who were heterosexually infected with HIV. 
Discussion
The present study, for the first time, examined prevalence and combinations of five pathogenic viral infections amongst Chinese HIV/AIDS patients. The prevalence of coinfections with HBV, HCV, EBV, HSV-1, and HSV-2 amongst HIV/AIDS patients was generally high. About 96% of the study subjects were infected with EBV and more than 90% of them were infected with HSV-1. This might be due to the high background prevalence of EBV and HSV-1 in the general Chinese population (28) (29) (30) . The prevalence of HBsAg among the HIV/AIDS patients was comparable to that in the general Chinese population which was 7.18% for those aged 1-59 years in a nationwide survey completed in 2006 among 81,775 participants (China Ministry of Health, April 21, 2008) . Although HCV and HSV-2 are both relatively uncommon in the general Chinese population (31, (19) (20) (21) , a high prevalence of HCV coinfection was observed among the study subjects who had contracted HIV through drug injections and plasma/blood donation or transfusion but a high prevalence of HSV-2 coinfection was also observed among those who had become HIV-infected through heterosexual transmission. Previous studies have reported that HCV infection is prevalent among former plasma donors and injection drug users and that HSV-2 infection is prevalent among commercial sex workers in China (15) (16) (22) (23) (24) . In this study, geographic region was also independently correlated with HCV and HSV-2 coinfection among HIV/AIDS patients. This may be due to different background levels of HCV and HSV-2 infections in different geographic regions (14) (15) (16) (19) (20) (21) (22) (23) (24) . Thus HCV and HSV-2 coinfections should be considered in areas where these viruses are common.
Gender was also found to be independently associated with HCV and HSV-2 coinfections among HIV/AIDS patients in this study. Females were less likely than males to have a HCV coinfection. This is probably related to the fact that in China females are generally less likely than males to be an IDU. A 2009 meta-analysis found that 84% of all IDU participating in the 1997-2007 studies included in the meta-analysis were men (32) . The present study found that female HIV patients were more likely than males to have an HSV-2 coinfection. This finding is consistent with a meta-analysis of HSV-1 and HSV-2 infections in regions throughout the globe which indicates that there tend to be a higher HSV-2 seroprevalence among females (17) . Other studies in China have also suggested that the increased prevalence of HSV-2 among women is associated with the growing commercial sex industry (19, (22) (23) (24) . Since HSV-2 is the major cause of genital herpes and HSV-2 coinfection can significantly accelerate sexual transmission of HIV, female HIV patients, particularly those who become HIV-infected through heterosexual transmission, should be tested for HSV-2 and treated if infected.
The present study also identified an association between ethnicity and an HCV or HSV-2 coinfection in HIV/AIDS patients. Those of Uygur, Dai and especially Jingpo ethnicities were more likely than ethnic Han to have an HCV coinfection and those of Dai and Jingpo ethnicities were less likely than ethnic Han to have an HSV-2 coinfection. Compared with ethnic Hans, these minorities have a higher percentage infected with HIV through injection drug use but have a lower percentage infected with HIV through sexual transmission. These findings suggest that minority HIV patients are more likely to contract viral coinfections from needle sharing than from heterosexual contacts.
An important finding of this study is that a combined total of 71.8% of the study subjects were coinfected with at least three other viruses which put them at risk for developing other diseases and malignancies that could significantly reduce their level of general health. The results of the present study also suggest the need to look for coinfections with other viruses such as EBV and HSV-1 which further threat the immune response.
This study has certain limitations. First, the determination of viral coinfections was based on crosssectional measurement of surface antigen for HBV and IgG antibody for HCV, EBV, HSV-1 and HSV-2 which only reflect historical exposure to the viruses. Thus, it is difficult to determine the temporal relationship between infections with HIV and the other viruses, limiting our ability to draw causal inferences about these viral coinfections. Second, we only tested for coinfections with HBV, HCV, EBV, HSV-1, and HSV-2. Due to the unavailability of blood-based, type-specific commercial products for testing, we did not test for human papillomavirus (HPV) which is also prevalent in China and is the causal agent of invasive cervical cancer, an important AIDS-defining disease. Also, due to lack of qualified commercial products for testing, we did not test for human herpes virus type 8 (HHV8) which was first identified in 1994 and has been demonstrated to be prevalent in the Mediterranean region and the causal agent of Kaposi's Sarcoma (KS), another important AIDS-defining disease (33) (34) (35) (36) . This limited our ability to draw conclusions with regard to the spectrum of viral coinfections that are of most significance to Chinese HIV/AIDS patients. Third, we only included HIV patients visiting local CDC for follow-up within the specified two-week sample collection period in the study, which compromised the representativeness of the study sample.
In conclusion, this study has demonstrated that most Chinese HIV/AIDS patients are living with multiple pathogenic viruses that may play important roles in their disease progression, responses to antiretroviral treatment and general health. It is foreseeable that the incidence of HIV-related malignancies such as HCC, NHL, HL, and nasopharyngeal cancer in China will increase given the high prevalence of HCV and EBV coinfections among HIV/AIDS patients and their extended lifetime gained from the nationwide antiretroviral treatment campaign. Moreover, Chinese HIV/AIDS patients with different backgrounds in terms of HIV transmission route, residential geographic region, gender and ethnicity may have different profiles of viral coinfections and thus should be subject to differential considerations in designing public health and clinical care programs for both HIV and other co-infected pathogenic viruses.
